Eli Lilly Rises Again as Stock Upgraded Following Mounjaro Sales Surge
Published
Eli Lilly stock was climbing again Wednesday after an analyst at Jefferies upgraded the stock following strong sales of the pharmaceutical giant’s diabetes drug, Mounjaro.
#elililly #jefferies